Erste Asset Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Buy
+230,000
New +$672K 0.01% 473
2024
Q4
Sell
-15,000
Closed -$52.2K 547
2024
Q3
$52.2K Hold
15,000
﹤0.01% 513
2024
Q2
$71.1K Hold
15,000
﹤0.01% 502
2024
Q1
$112K Hold
15,000
﹤0.01% 486
2023
Q4
$155K Hold
15,000
﹤0.01% 491
2023
Q3
$104K Hold
15,000
﹤0.01% 500
2023
Q2
$122K Hold
15,000
﹤0.01% 513
2023
Q1
$105K Hold
15,000
﹤0.01% 528
2022
Q4
$135K Hold
15,000
﹤0.01% 525
2022
Q3
$182K Hold
15,000
﹤0.01% 501
2022
Q2
$183K Hold
15,000
﹤0.01% 515
2022
Q1
$293K Buy
+15,000
New +$279K 0.01% 484
2021
Q4
Sell
-19,000
Closed -$808K 541
2021
Q3
$808K Hold
19,000
0.02% 357
2021
Q2
$876K Hold
19,000
0.02% 356
2021
Q1
$770K Hold
19,000
0.02% 349
2020
Q4
$1.42M Hold
19,000
0.04% 304
2020
Q3
$552K Buy
19,000
+6,000
+46% +$195K 0.02% 345
2020
Q2
$381K Hold
13,000
0.02% 355
2020
Q1
$263K Hold
13,000
0.02% 337
2019
Q4
$396K Hold
13,000
0.02% 337
2019
Q3
$292K Hold
13,000
0.02% 347
2019
Q2
$304K Hold
13,000
0.02% 348
2019
Q1
$307K Hold
13,000
0.02% 335
2018
Q4
$264K Buy
+13,000
New +$354K 0.02% 348

Other funds holding EDIT

Erste Asset Management's EDIT Position: Q2 2026 in Review

Erste Asset Management opened a new position in Editas Medicine (EDIT) in Q2 2026: 230,000 shares worth $736K. The stake represents 0.01% of the portfolio and ranks #473 among its holdings. This is a return to the name: Erste Asset Management previously reported a position in EDIT as recently as Q3 2024.

Erste Asset Management first reported a position in EDIT in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.42M in Q4 2020. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Erste Asset Management held 230,000 shares of Editas Medicine worth $736K as of Q2 2026.
  • Editas Medicine was a new Erste Asset Management position in Q2 2026.
  • Editas Medicine made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #473 holding.
  • Erste Asset Management first reported a position in Editas Medicine in Q4 2018 and has held it in 24 quarters since.
  • Erste Asset Management's Editas Medicine position peaked at $1.42M in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.